Dezhan Healthcare Co (SZSE:000813) E10: ¥0.12 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:000813 Dezhan Healthcare Co Ltd SZSE:000813
61 GF Score
Price ¥3.38
GF Value ¥2.71
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Dezhan Healthcare Co E10?

Dezhan Healthcare Co SZSE:000813 +0.60% 61 E10 is ¥0.12 as of Jun. 2026. GuruFocus rates SZSE:000813 with a GF Score™ of 61/100 and a GF Value™ of ¥2.71 (Modestly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Dezhan Healthcare Co's adjusted earnings per share data for the three months ended in Jun. 2026 was ¥-0.011. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.12 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Dezhan Healthcare Co's average E10 Growth Rate was -36.80% per year. During the past 3 years, the average E10 Growth Rate was -9.10% per year. During the past 5 years, the average E10 Growth Rate was -4.00% per year. During the past 10 years, the average E10 Growth Rate was 11.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Dezhan Healthcare Co was 86.60% per year. The lowest was -9.10% per year. And the median was 12.15% per year.

As of today (2026-09-13), Dezhan Healthcare Co's current stock price is ¥3.38. Dezhan Healthcare Co's E10 for the quarter that ended in Jun. 2026 was ¥0.12. Dezhan Healthcare Co's Shiller PE Ratio of today is 28.17.

During the past 13 years, the highest Shiller PE Ratio of Dezhan Healthcare Co was 171.62. The lowest was 10.40. And the median was 24.57.


Dezhan Healthcare Co  (SZSE:000813) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Dezhan Healthcare Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=3.38/0.12
=28.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Dezhan Healthcare Co was 171.62. The lowest was 10.40. And the median was 24.57.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Dezhan Healthcare Co E10 Related Terms


Dezhan Healthcare Co E10 Historical Data

* Premium members only.

The historical data trend for Dezhan Healthcare Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dezhan Healthcare Co E10 Chart

Dezhan Healthcare Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.20 0.20 0.20 0.20 0.15

Dezhan Healthcare Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.18 0.15 0.14 0.12

SZSE:000813 vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Dezhan Healthcare Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dezhan Healthcare Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dezhan Healthcare Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Dezhan Healthcare Co's Shiller PE Ratio falls into.


SZSE:000813
61GF Score
Dezhan Healthcare Co Ltd SZSE:000813
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dezhan Healthcare Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Dezhan Healthcare Co's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.011/116.0564*116.0564
=-0.011

Current CPI (Jun. 2026) = 116.0564.

Dezhan Healthcare Co Quarterly Data

per share eps CPI Adj_EPS
201609 0.149 102.400 0.169
201612 0.063 102.600 0.071
201703 0.073 103.200 0.082
201706 0.118 103.100 0.133
201709 0.092 104.100 0.103
201712 0.073 104.500 0.081
201803 0.079 105.300 0.087
201806 0.119 104.900 0.132
201809 0.128 106.600 0.139
201812 0.090 106.500 0.098
201903 0.055 107.700 0.059
201906 0.055 107.700 0.059
201909 0.043 109.800 0.045
201912 -0.001 111.200 -0.001
202003 0.041 112.300 0.042
202006 0.041 110.400 0.043
202009 0.026 111.700 0.027
202012 0.020 111.500 0.021
202103 0.029 112.662 0.030
202106 0.017 111.769 0.018
202109 0.010 112.215 0.010
202112 -0.081 113.108 -0.083
202203 0.014 114.335 0.014
202206 0.016 114.558 0.016
202209 0.000 115.339 0.000
202212 -0.051 115.116 -0.051
202303 0.001 115.116 0.001
202306 -0.004 114.558 -0.004
202309 0.032 115.339 0.032
202312 0.010 114.781 0.010
202403 -0.008 115.227 -0.008
202406 0.013 114.781 0.013
202409 -0.001 115.785 -0.001
202412 -0.013 114.893 -0.013
202503 -0.010 115.116 -0.010
202506 -0.010 114.907 -0.010
202509 -0.009 115.471 -0.009
202512 -0.135 115.832 -0.135
202603 -0.016 116.303 -0.016
202606 -0.011 116.056 -0.011

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ¥0.12 mean?
Dezhan Healthcare Co (SZSE:000813) has a E10 of ¥0.12 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Dezhan Healthcare Co and its competitors.
Is Dezhan Healthcare Co's E10 too high?
Dezhan Healthcare Co's current E10 is ¥0.12. Overall, Dezhan Healthcare Co has a GF Score™ of 61/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dezhan Healthcare Co's E10 compare to ZTS?
Dezhan Healthcare Co's E10 of ¥0.12 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Dezhan Healthcare Co and its competitors. Dezhan Healthcare Co's current E10 is ¥0.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dezhan Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Dezhan Healthcare Co (SZSE:000813) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥2.71, compared to a current price of ¥3.38 — trading 24.7% above its estimated fair value. The current E10 is ¥0.12. Dezhan Healthcare Co's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Dezhan Healthcare Co (SZSE:000813), the current E10 is ¥0.12 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dezhan Healthcare Co (SZSE:000813) Overvalued in 2026?

Based on GuruFocus' analysis, Dezhan Healthcare Co stock appears to be overvalued. The current stock price of ¥3.38 is trading 24.7% above its estimated GF Value™ of ¥2.71. GuruFocus considers Dezhan Healthcare Co to be Modestly Overvalued.

Key valuation signals for SZSE:000813:

  • E10: ¥0.12
  • GF Value™: ¥2.71 vs. price of ¥3.38 (24.7% above fair value)
  • GF Score™: 61/100 with 4 warning signs

No single metric tells the full story. See the SZSE:000813 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dezhan Healthcare Co Business Description

Address No. 235 Yin Chuan Road, Xinjiang, Urumqi, CHN, 830054
Dezhan Healthcare Co Ltd's main business is drug research and development, production, and sales. The company's wholly-owned subsidiary Jialin Pharmaceuticals mainly engages in the research and development, production, and sale of cardiovascular drugs, the drugs being produced and sold including Ale (10mg), Alle (20mg), hydrochloric acid quercetine capsules, Van Le tablets type 1, Van Le tablets.
61GF Score

Get the complete analysis for SZSE:000813

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥3.38
Price
¥2.71
GF Value